Liliane Fossati-Jimack

Dr. Liliane Fossati-Jimack is a Senior Manager and Senior Scientific Officer at Queen Mary University of London's Department of Experimental Medicine and Rheumatology, part of the Faculty of Medicine and Dentistry. She holds a PhD in Biology from the University of Geneva (Switzerland), with early research focused on immune dysregulation in Systemic Lupus Erythematosus (SLE). Her career shifted to Rheumatoid Arthritis (RA) at Queen Mary, where she co-managed landmark clinical trials such as R4RA and STRAP. Her work contributed to the Lancet publication of the R4RA trial (2021), evaluating therapies for anti-TNF non-responders with RA. She currently leads as Senior Project Manager, overseeing scientific and managerial aspects of key studies.

Education: BSc and PhD in Biology from the University of Geneva, Switzerland.

Research interests center on autoimmune diseases, particularly SLE and RA, with emphasis on immune mechanisms and clinical trial development. Her work spans translational research, including immunological pathways in autoimmunity and therapeutic interventions. Recent publications focus on B-cell depletion therapies and clinical trial outcomes in RA, while earlier studies explored genetic and molecular drivers of lupus in murine models.

Key projects include the R4RA trial comparing rituximab and tocilizumab, and the STRAP trial. No scientific awards are explicitly listed, but contributions to high-impact trials highlight her expertise. No formal advisee list exists, though she collaborates extensively on multi-center studies.

Labs/Teams: Active within the Centre for Experimental Medicine and Rheumatology at Queen Mary, contributing to interdisciplinary teams focused on autoimmune disease research and clinical translation.